Paula F. Holland v. HHS - Influenza, Guillain-Barré Syndrome (“GBS”) and GBS-caused chronic inflammatory demyelinating polyneuropathy (“CIDP”) (2017)

Paula F. Holland filed a petition for compensation under the National Vaccine Injury Compensation Program on September 23, 2014, alleging that she suffered Guillain-Barré Syndrome (GBS) and GBS-caused chronic inflammatory demyelinating polyneuropathy (CIDP) as a result of receiving an influenza vaccine on October 2, 2012.

She asserted that the vaccine was administered in the United States, that she experienced residual effects for more than six months, and that there had been no prior award or settlement for her condition. Respondent denied that the flu vaccine caused her injuries.

Despite the denial, the parties filed a joint stipulation on November 14, 2016, agreeing that compensation should be awarded. The Chief Special Master found the stipulation reasonable and adopted it as the Court's decision.

Paula F. Holland was awarded a total of $916,741.63, comprising a lump sum of $689,591.32 for life care expenses, lost earnings, and pain and suffering, and a lump sum of $25,150.31 to reimburse a lien.

An additional amount was allocated for an annuity contract. Judgment was to be entered in accordance with this decision.